Aeon Metals Ltd
ASX:AML
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aeon Metals Ltd
ASX:AML
|
AU |
|
JW Pharmaceutical Corp
KRX:001060
|
KR |
|
Jayden Resources Inc
XTSX:JDN
|
CA |
|
Jiangsu Canlon Building Materials Co Ltd
SZSE:300715
|
CN |
|
S
|
Sinofibers Technology Co Ltd
SZSE:300777
|
CN |
|
M
|
Musti Group Oyj
OMXH:MUSTI
|
FI |
|
Maan Aluminium Ltd
NSE:MAANALU
|
IN |
|
N
|
Netbrands Corp
OTC:NBND
|
US |
|
Frontier Digital Ventures Ltd
ASX:FDV
|
MY |
Balance Sheet
Balance Sheet Decomposition
Aeon Metals Ltd
Aeon Metals Ltd
Balance Sheet
Aeon Metals Ltd
| Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
5
|
2
|
7
|
2
|
13
|
7
|
2
|
1
|
2
|
1
|
|
| Cash |
0
|
0
|
0
|
2
|
13
|
7
|
2
|
1
|
2
|
1
|
|
| Cash Equivalents |
5
|
2
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
6
|
2
|
7
|
2
|
13
|
7
|
3
|
1
|
2
|
1
|
|
| PP&E Net |
43
|
43
|
50
|
55
|
63
|
76
|
80
|
84
|
97
|
105
|
|
| PP&E Gross |
43
|
0
|
0
|
0
|
63
|
76
|
80
|
84
|
97
|
105
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
49
N/A
|
45
-8%
|
57
+26%
|
57
0%
|
77
+34%
|
83
+9%
|
83
0%
|
85
+3%
|
99
+16%
|
106
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
32
|
0
|
0
|
0
|
25
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
1
|
1
|
33
|
2
|
2
|
1
|
27
|
2
|
1
|
|
| Long-Term Debt |
12
|
16
|
24
|
0
|
15
|
13
|
19
|
0
|
28
|
35
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
14
N/A
|
17
+21%
|
25
+46%
|
33
+33%
|
17
-49%
|
15
-10%
|
20
+32%
|
27
+33%
|
30
+11%
|
36
+22%
|
|
| Equity | |||||||||||
| Common Stock |
43
|
45
|
48
|
48
|
90
|
108
|
108
|
108
|
123
|
127
|
|
| Retained Earnings |
8
|
17
|
16
|
24
|
30
|
40
|
45
|
50
|
53
|
57
|
|
| Total Equity |
36
N/A
|
29
-19%
|
33
+14%
|
24
-25%
|
60
+146%
|
68
+14%
|
63
-7%
|
59
-7%
|
70
+19%
|
70
+1%
|
|
| Total Liabilities & Equity |
49
N/A
|
45
-8%
|
57
+26%
|
57
0%
|
77
+34%
|
83
+9%
|
83
0%
|
85
+3%
|
99
+16%
|
106
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
272
|
297
|
341
|
348
|
586
|
673
|
678
|
692
|
1 005
|
1 111
|
|